Kinetoplastid RNA editing
动质体RNA编辑
基本信息
- 批准号:10200087
- 负责人:
- 金额:$ 35.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-13 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinity ChromatographyAntibodiesBindingBioenergeticsBioinformaticsBlood CirculationCo-ImmunoprecipitationsComplexDataDefectDevelopmentDevelopmental ProcessDiscriminationEssential GenesFoundationsFutureGenerationsGoalsGrowthGuide RNAHeterogeneityHigh-Throughput Nucleotide SequencingHoloenzymesHumanImmunoprecipitationIn VitroInsect VectorsInsectaKnowledgeLaboratoriesLeftLengthLifeLife Cycle StagesMass Spectrum AnalysisMediator of activation proteinMedicalMessenger RNAMitochondriaMitochondrial ProteinsModelingMolecularNucleotidesOrganismParasitesPatternPlayPoly APositioning AttributeProcessProteinsPublishingRNARNA BindingRNA EditingRNA InterferenceRegulationRegulator GenesResolutionRibonucleoproteinsRoleSiteSystemTailTechnologyTestingTrypanosomaTrypanosoma brucei bruceiUridineVirulenceWorkbioinformatics tooldrug developmentenzyme mechanisminnovationinsertion/deletion mutationinsightknock-downmitochondrial messenger RNAmutantnovelprotein complexprotein functionprotein protein interactionrecruitscaffoldtooltraffickingtranscriptome
项目摘要
RNA editing in kinetoplastid parasites entails massive remodeling of mitochondrial mRNAs by
posttranscriptional insertion and deletion of uridine (U) residues to generate mRNAs encoding proteins
involved in parasite bioenergetics. U insertion/deletion RNA editing is unique to kinetoplastids and essential for
T. brucei survival and virulence. The RNA editing holoenzyme comprises two subcomplexes: RECC (RNA
Editing Core Complex) and RESC (RNA Editing Substrate Binding Complex). Trans-acting guide RNAs
(gRNAs) direct U insertion/deletion, acting sequentially such that editing proceeds 3' to 5' along an mRNA.
RECC contains the editing enzymes, and the mechanisms by which RECC catalyzes U insertion/deletion at a
single editing site have been extensively studied. More recently, RESC has emerged as the scaffold for editing
and a coordinator of interactions between mRNAs, gRNAs, and RECC, although the mechanisms by which it
accomplishes these tasks are essentially unknown. Adding even more complexity, editing of specific mRNAs is
differentially regulated between human bloodstream form (BF) and insect vector procyclic form (PF) parasites.
The mechanism(s) of developmental regulation, and the precise point(s) in the life cycle at which they are
effected, remain entirely mysterious. The goals of this application are to (1) delineate the roles of distinct
components of RESC and a novel RESC-related complex in gRNA trafficking and utilization, and (2) to define
aspects of the editing process that serve as control points for stage specific regulation during the T. brucei life
cycle. To accomplish these goals, we developed an innovative and powerful bioinformatic tool (HTS/TREAT)
that permits us to now examine the mitochondrial transcriptome at single nucleotide resolution, and group
partially edited mRNA intermediates in ways that illuminate specific aspects of gRNA usage. Combining this
bioinformatic approach with RNA immunoprecipitation and protein-protein interaction studies, we will define the
mechanisms by which specific RESC proteins function, correlate these to RESC heterogeneity and dynamic
interactions, and elucidate the steps in the editing process that are developmentally controlled. We will also
take advantage of recent technology that permits generation of substantial numbers of insect metacyclic form
(MF) T. brucei, a largely unexplored intermediate between PF and BF. Using HTS/TREAT, we will define the
patterns of RNA editing in MFs, and reveal whether BF RNA editing patterns for some or all mRNAs emerge in
MFs, providing insight into the temporal control of RNA editing during T. brucei development. The proposed
studies address several important gaps in knowledge regarding the essential kinetoplastid RNA editing
process. Moreover, this work may help lay the foundation for future drug development and provide important
insights into ribonucleoprotein complex function in higher organisms.
动力质体寄生虫中的RNA编辑需要对线粒体mRNA进行大规模重塑
转录后插入和缺失尿苷(U)残基生成编码蛋白质的mRNA
参与寄生虫生物能学。 u插入/删除RNA编辑是动力质体独有的,对于
T. Brucei的生存和毒力。 RNA编辑Holoenzyme包括两个子复合:RECC(RNA
编辑核心复合物)和rec(RNA编辑底物结合复合物)。反式指南RNA
(grnas)直接插入/缺失,顺序起作用,使编辑沿mRNA进行3'至5'。
RECC包含编辑酶,以及RECC催化u插入/缺失的机制
单个编辑网站已进行了广泛的研究。最近,Resc已成为编辑的脚手
以及mRNA,GRNA和RECC之间相互作用的协调员,尽管它的机制
完成这些任务本质上是未知的。添加更复杂性,特定mRNA的编辑是
在人体血液形式(BF)和昆虫载体形式(PF)寄生虫之间进行了差异调节。
发育调节的机制以及生命周期中的精确点
有效,仍然完全神秘。该应用的目标是(1)描述不同的角色
RESC的组成部分以及一种新型的GRNA贩运和利用中的与救援相关的复合物,以及(2)定义
编辑过程的各个方面,作为在T. Brucei Life期间作为阶段特定调节的控制点
循环。为了实现这些目标,我们开发了一种创新且强大的生物信息学工具(HTS/Treat)
这使我们现在可以检查单核苷酸分辨率的线粒体转录组,并检查组
部分编辑了mRNA中间体,以照亮GRNA使用的特定方面。结合这个
RNA免疫沉淀和蛋白质 - 蛋白质相互作用研究的生物信息学方法,我们将定义
特定救援蛋白功能的机制,将它们与救援异质性和动态性相关联
相互作用,并阐明在编辑过程中受发展控制的步骤。我们也会
利用最近允许生成大量昆虫元环境形式的技术
(MF)T。Brucei,PF和BF之间的一个未开发的中间体。使用HTS/Treat,我们将定义
MFS中的RNA编辑模式,并揭示BF RNA编辑模式是否出现在某些或全部mRNA中
MFS,提供对T. Brucei开发过程中RNA编辑的时间控制的见解。提议
研究解决了有关基本动力质体RNA编辑知识的几个重要差距
过程。此外,这项工作可能有助于为未来的药物开发奠定基础,并提供重要的
对较高生物体中核糖核蛋白复合物功能的见解。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Developmental dynamics of mitochondrial mRNA abundance and editing reveal roles for temperature and the differentiation-repressive kinase RDK1 in cytochrome oxidase subunit II mRNA editing.
- DOI:10.1128/mbio.01854-23
- 发表时间:2023-10-31
- 期刊:
- 影响因子:6.4
- 作者:
- 通讯作者:
High throughput sequencing revolution reveals conserved fundamentals of U-indel editing.
高通量测序革命揭示了 U-indel 编辑的保守基础。
- DOI:10.1002/wrna.1487
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Zimmer,SaraL;Simpson,RachelM;Read,LaurieK
- 通讯作者:Read,LaurieK
Developmental regulation of edited CYb and COIII mitochondrial mRNAs is achieved by distinct mechanisms in Trypanosoma brucei.
布氏锥虫中编辑的 CYb 和 COIII 线粒体 mRNA 的发育调节是通过不同的机制实现的。
- DOI:10.1093/nar/gkaa641
- 发表时间:2020
- 期刊:
- 影响因子:14.9
- 作者:SmithJr,JosephT;Doleželová,Eva;Tylec,Brianna;Bard,JonathanE;Chen,Runpu;Sun,Yijun;Zíková,Alena;Read,LaurieK
- 通讯作者:Read,LaurieK
Trypanosome RNAEditing Substrate Binding Complex integrity and function depends on the upstream action of RESC10.
- DOI:10.1093/nar/gkab129
- 发表时间:2021-04-06
- 期刊:
- 影响因子:14.9
- 作者:Dubey AP;Tylec BL;McAdams NM;Sortino K;Read LK
- 通讯作者:Read LK
Intrinsic and regulated properties of minimally edited trypanosome mRNAs.
最低限度编辑的锥虫 mRNA 的内在和调控特性。
- DOI:10.1093/nar/gkz012
- 发表时间:2019
- 期刊:
- 影响因子:14.9
- 作者:Tylec,BriannaL;Simpson,RachelM;Kirby,LauraE;Chen,Runpu;Sun,Yijun;Koslowsky,DonnaJ;Read,LaurieK
- 通讯作者:Read,LaurieK
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laurie K. Read其他文献
Laurie K. Read的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laurie K. Read', 18)}}的其他基金
Alternative polyadenylation regulation in Trypanosoma brucei
布氏锥虫的替代多腺苷酸化调控
- 批准号:
10584834 - 财政年份:2022
- 资助金额:
$ 35.04万 - 项目类别:
Function and regulation of the essential RNA binding protein, DRBD18
必需 RNA 结合蛋白 DRBD18 的功能和调节
- 批准号:
10649589 - 财政年份:2019
- 资助金额:
$ 35.04万 - 项目类别:
Function and regulation of the essential RNA binding protein, DRBD18
必需 RNA 结合蛋白 DRBD18 的功能和调节
- 批准号:
9811587 - 财政年份:2019
- 资助金额:
$ 35.04万 - 项目类别:
Function and regulation of the essential RNA binding protein, DRBD18
必需 RNA 结合蛋白 DRBD18 的功能和调节
- 批准号:
10404501 - 财政年份:2019
- 资助金额:
$ 35.04万 - 项目类别:
Posttranslational modification of the regulatory RNA binding protein, ZFP3
调节性 RNA 结合蛋白 ZFP3 的翻译后修饰
- 批准号:
9163318 - 财政年份:2016
- 资助金额:
$ 35.04万 - 项目类别:
Posttranslational modification of the regulatory RNA binding protein, ZFP3
调节性 RNA 结合蛋白 ZFP3 的翻译后修饰
- 批准号:
9298582 - 财政年份:2016
- 资助金额:
$ 35.04万 - 项目类别:
Cis- and trans-acting factors in mitochondrial RNA decay
线粒体 RNA 衰减中的顺式和反式作用因子
- 批准号:
7798222 - 财政年份:2008
- 资助金额:
$ 35.04万 - 项目类别:
Cis- and trans-acting factors in mitochondrial RNA decay
线粒体 RNA 衰减中的顺式和反式作用因子
- 批准号:
7617872 - 财政年份:2008
- 资助金额:
$ 35.04万 - 项目类别:
Cis- and trans-acting factors in mitochondrial RNA decay
线粒体 RNA 衰减中的顺式和反式作用因子
- 批准号:
7433401 - 财政年份:2008
- 资助金额:
$ 35.04万 - 项目类别:
Cis- and trans-acting factors in mitochondrial RNA decay
线粒体 RNA 衰减中的顺式和反式作用因子
- 批准号:
8053468 - 财政年份:2008
- 资助金额:
$ 35.04万 - 项目类别:
相似国自然基金
基于仿生亲和色谱-质谱策略的肺结核患者血清抗体谱研究
- 批准号:82160027
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
以温敏树枝状聚合物为间隔臂的高容量温敏仿生亲和色谱及对抗体的分离纯化
- 批准号:21874106
- 批准年份:2018
- 资助金额:65.0 万元
- 项目类别:面上项目
利用免疫亲和色谱技术解析芍药苷、甘草酸与芍药甘草汤功效的关联机制
- 批准号:81573573
- 批准年份:2015
- 资助金额:63.0 万元
- 项目类别:面上项目
基于特异性敲除技术的芍药甘草汤配伍机制的研究
- 批准号:81373542
- 批准年份:2013
- 资助金额:16.0 万元
- 项目类别:面上项目
检测环境中抗生素PPCPs的前处理方法学研究
- 批准号:21107104
- 批准年份:2011
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel, Targeted Method for Bacteriophage Purification
噬菌体纯化的新型靶向方法
- 批准号:
10698983 - 财政年份:2023
- 资助金额:
$ 35.04万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 35.04万 - 项目类别:
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
量化血浆中的蛋白质确实使 1 型糖尿病患者的个性化医疗民主化
- 批准号:
10730284 - 财政年份:2023
- 资助金额:
$ 35.04万 - 项目类别:
Small Molecule Probes for Fluorescence-guided Head and Neck Cancer Surgery
用于荧光引导头颈癌手术的小分子探针
- 批准号:
10644519 - 财政年份:2023
- 资助金额:
$ 35.04万 - 项目类别:
Proteasome Inhibitor-Loaded Antibody Drug Conjugates with High Drug Loading For Targeted Treatment of Triple Negative Breast Cancers
负载蛋白酶体抑制剂的高载药量抗体药物偶联物用于三阴性乳腺癌的靶向治疗
- 批准号:
10822628 - 财政年份:2023
- 资助金额:
$ 35.04万 - 项目类别: